- Home
- » Tags
- » CYP17A1 inhibitor
Top View
- Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer Response to Castration and Drug Treatment Michael V
- Phase 1/2 Trial of Orteronel (TAK-700) – an Investigational 17,20-Lyase
- Enzalutamide Therapy for Advanced Prostate Cancer: Efficacy, Resistance and Beyond
- Evaluation of Darolutamide (ODM201) Efficiency on Androgen
- Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor
- (12) United States Patent (10) Patent No.: US 9,512,169 B2 Bothe Et Al
- Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer
- Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
- Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: the Fight Goes On
- Practical Guide to the Use of Abiraterone in Castration Resistant Prostate Cancer Elahe A
- Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
- Interactions of Abiraterone, Eplerenone, and Prednisolone With
- An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
- Circulating Steroid Hormone Variations Throughout Different Stages of Prostate Cancer
- Outcome of Combination Chemotherapy with Docetaxel
- Phase 1 Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor
- A Population Pharmacokinetic Analysis of the Oral CYP17 Lyase
- Effects and Modes of Action of Exogenous Androgens on Gonadal Steroidogenesis in Male Mummichog (Fundulus Heteroclitus)
- Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer Shilpa Gupta1, Luke T
- Resistant Prostate Cancer Paul J
- CYP17A1 Inhibitor Abiraterone, an Anti-Prostate Cancer Drug
- Androgen Receptor Antagonists for Prostate Cancer Therapy
- CYP17A1) Gene Variants for Their Steroidogenic Enzymatic Activities
- Inhibiting Steroid Biosynthesis in Prostate Cancer
- Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor
- Alternative Androgen Metabolism in Resistance to Aromatase Inhibitors by Matthew Joseph Sikora
- Orphan Nuclear Receptors As Regulators of Intratumoral Androgen Biosynthesis in Castration-Resistant Prostate Cancer